Sadamatsu Hironori, Kurihara Yuki, Takahashi Koichiro, Komiya Kazutoshi, Ogusu Shinsuke, Hirakawa Haruki, Tashiro Hiroki, Nakashima Chiho, Nakamura Tomomi, Sueoka-Aragane Naoko
Division of Haematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Case Rep Oncol. 2019 Jun 26;12(2):466-472. doi: 10.1159/000501305. eCollection 2019 May-Aug.
Paraneoplastic limbic encephalitis (PLE) is a rare neurologic disorder that can complicate various malignancies, including lung cancer. PLE is most frequently found the initial presentation of lung cancer. In this study, we reported the case of a 74-year-old Japanese woman who developed PLE after partial remission of small cell lung cancer (SCLC) by first-line systemic chemotherapy. Brain magnetic resonance imaging showed no metastatic tumor or cerebrovascular disease. Anti-glutamic acid decarboxylase (GAD) and anti-amphiphysin antibodies were detected in her serum. She was diagnosed as having PLE related to the recurrence of SCLC and received high-dose glucocorticoid, and sequentially systemic chemotherapy with amrubicin. Unfortunately, these treatments did not improve her disease progression and she died 4 months later. Although PLE rarely occurs at the time of SCLC recurrence, physicians should pay attention to PLE onset even after chemotherapy.
副肿瘤性边缘叶脑炎(PLE)是一种罕见的神经系统疾病,可并发于包括肺癌在内的各种恶性肿瘤。PLE最常出现在肺癌的初始表现中。在本研究中,我们报告了一例74岁的日本女性病例,该患者在一线全身化疗使小细胞肺癌(SCLC)部分缓解后发生了PLE。脑磁共振成像显示无转移瘤或脑血管疾病。在她的血清中检测到抗谷氨酸脱羧酶(GAD)和抗 amphiphysin 抗体。她被诊断为与SCLC复发相关的PLE,并接受了大剂量糖皮质激素治疗,随后接受了氨柔比星全身化疗。不幸的是,这些治疗并未改善她的疾病进展,4个月后她去世了。尽管PLE在SCLC复发时很少发生,但医生即使在化疗后也应注意PLE的发病。